<DOC>
	<DOC>NCT00538421</DOC>
	<brief_summary>Comparing 2 different anaesthetic methods during abdominal aortic aneurysm surgery. The patients will be followed up 30 days postoperative. Number of patients included will be 200. Perioperative details will be analyzed.</brief_summary>
	<brief_title>Opioid-potentiated Volative Anaesthetic Vs. Remifentanil And Propofol During Abdominal Aortic Aneurysm Surgery</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
	<mesh_term>Aortic Diseases</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>Patients who are planned for open, elective abdominal aortic aneurysm surgery. ASA group 14. Patients below 18 years. Patients who are included in other pharmaceutical studies. Opioids, benzodiazepins, antiepileptic drugs, alcohol and Î±2agonists abuse. Pregnant and breastfeeding women. Patients with familiar history of malignant hyperthermia. Patients with known hypersensitivity for opioids, propofol or volative anaesthetics. Patients with considerable arrythmia (atrial fibrillation /atrial flutter is acceptable). Uncontrolled hypertension, serious psychiatric disease. Patients with unstable angina pectoris or myocardial infarction last month before inclusion. Acute abdominal aortic surgery. Acute dissection or rupture. Planned laparoscopic abdominal aortic aneurysm surgery.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>propofol</keyword>
	<keyword>Anaesthesia</keyword>
	<keyword>Sevoflurane</keyword>
	<keyword>Abdominal</keyword>
	<keyword>Aortic</keyword>
	<keyword>Aneurysm</keyword>
</DOC>